| Budget Amount *help |
¥17,420,000 (Direct Cost: ¥13,400,000、Indirect Cost: ¥4,020,000)
Fiscal Year 2022: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2021: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2020: ¥8,970,000 (Direct Cost: ¥6,900,000、Indirect Cost: ¥2,070,000)
|
|---|
| Outline of Final Research Achievements |
The proto-oncogene product Src is upregulated in many cancer tissues, and it has been shown that Src-related signaling pathways are involved in the expression of various cancer traits such as cell growth and invasion. In this study, we analyzed the mechanism of cancer-specific exosome upregulation by Src to elucidate the action of Src signaling in the establishment of the cancer microenvironment via exosomes.
|
